Approvals/TGA/CONTRAVE 8/90 naltrexone hydrochloride 8 mg and bupropion hydrochloride 90 mg modified-release tablet blister pack

Approved

STANDARD

CONTRAVE 8/90 naltrexone hydrochloride 8 mg and bupropion hydrochloride 90 mg modified-release tablet blister pack

Approval Id: 5aad5cb0c950b0b9
Product Name: CONTRAVE 8/90 naltrexone hydrochloride 8 mg and bupropion hydrochloride 90 mg modified-release tablet blister pack
Artg Id: 288372
Artg Name: CONTRAVE 8/90 naltrexone hydrochloride 8 mg and bupropion hydrochloride 90 mg modified-release tablet blister pack
Sponsor: iNova Pharmaceuticals (Australia) Pty Ltd
Company Detail Path: /organization/inova-pharmaceuticals-australia-pty-limited
Artg Date: 2018-08-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/898cb27b66ff47da723696c830b32f72.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e98bd2e523f867941d44505f6e7cbeb7.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

5aad5cb0c950b0b9

Type

Standard